SI-2 HCl (EPH 116 HCl) is a highly promising SRC-3 SMI: SRC-3 inhibitor (PPI), with IC50 values of 3-20 nM for breast cancer cell death. SI-2 HCl (EPH 116 HCl) has a much improved toxicity and pharmacokinetic profile, with acceptable oral availability. References: [1]. Song X, et al. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A. 2016 May 3;113(18):4970-5.

纯度：≥98%

CAS：1992052-49-9